References
Hlatky MA, Reynolds M, Turakhia M. Foreword: health policy and cardiac electrophysiology. J Interv Card Electrophysiol. 2013;36:97.
Dhruva SS, Redberg RF. FDA regulation of cardiovascular devices and opportunities for improvement. J Interv Card Electrophysiol. 2013;36:99–105.
Sharma A, Blank A, Patel P, et al. Health care policy and regulatory implications on medical device innovations: a cardiac rhythm medical device industry perspective. J Interv Card Electrophysiol. 2013;36:107–17.
Blake K. Postmarket surveillance of medical devices: current capabilities and future opportunities. J Interv Card Electrophysiol. 2013;36:119–27.
Turakhia MP, Ullal AJ. US health care policy and reform: implications for cardiac electrophysiology. J Interv Card Electrophysiol. 2013;36:129–36.
Roka A, Schoenfeld MH. The pathway to physician reimbursement for cardiac implantable electronic devices (CIEDs): a history and brief synopsis. J Interv Card Electrophysiol. 2013;36:137–44.
Al-Khatib SM. Quality improvement in heart rhythm care: the path forward. J Interv Card Electrophysiol. 2013;36:145–9.
Hlatky MA. Volume, outcome, and policy. J Interv Card Electrophysiol. 2013;36:151–5.
Winkle RA, Mead RH, Engel G, et al. Physician-controlled costs: the choice of equipment used for atrial fibrillation ablation. J Interv Card Electrophysiol. 2013;36:157–65.
Dougherty KR, Friedman RA, Link MS, et al. Prediction and prevention of sudden death in young populations: the role of ECG screening. J Interv Card Electrophysiol. 2013;36:167–75.
Ha ACT, Dorian P. Health-related quality of life questionnaires: an important method to evaluate patient outcomes in atrial fibrillation ablation. J Interv Card Electrophysiol. 2013;36:177–84.
Joyce KE, Lord S, Matlock DD, et al. Incorporating the patient perspective: a critical review of clinical practice guidelines for implantable cardioverter defibrillator therapy. J Interv Card Electrophysiol. 2013;36:185–97.
Ray JC, Kusumoto FM. The transition to value-based care. J In Card Electrophysiol. 2016; xxx.
Friedman DJ, Al-Khatib SM. Measuring quality in electrophysiology. J In Card Electrophysiol. 2016; xxx.
Fisher WG, Schloss EJ. Medical specialty certification in the United States—a false idol?. J In Card Electrophysiol. 2016; xxx.
Selzman KA, Fellman M, Farb A, de del Castillo S, Zuckerman B. New technology in electrophysiology: FDA process and perspective. J In Card Electrophysiol. 2016; xxx.
Govil A, Hao SC. Integration of new technology into clinical practice after FDA approval. J In Card Electrophysiol. 2016; xxx.
Austin C, Kusumoto FM. The application of big data: clinical implications and future directions. J In Card Electrophysiol. 2016; xxx.
Slotwiner DJ. Electronic health records and cardiac implantable electronic devices: new paradigms and efficiencies. J In Card Electrophysiol. 2016; xxx.
Turakhia MP, Kaiser DW. Transforming the care of atrial fibrillation with mobile health. J In Card Electrophysiol. 2016; xxx.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kusumoto, F. Introduction: health policy II. A new era of heath policy in electrophysiology and cardiology. J Interv Card Electrophysiol 47, 1–3 (2016). https://doi.org/10.1007/s10840-016-0182-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10840-016-0182-x